A 12 week multicenter study consisting of a 6 week double blind, randomized, vehicle controlled, parallel group phase, followed by a 6 week open label phase, to assess the safety and efficacy of Elidel Cream 1% in mild to moderate head and neck atopic dermatitis of patients intolerant of topical corticosteroids